Gryfe R, Di Nicola N, Gallinger S, Redston M
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Department of Surgery, The University of Toronto, Ontario, Canada.
Cancer Res. 1998 Sep 15;58(18):4040-3.
The adenomatous polyposis coli (APC) gene is proposed to function as a gatekeeper of colorectal neoplasia. A germ-line variant of this gene, the APC I1307K allele, is present in approximately 6% of the Ashkenazi Jewish population. To assess the role in tumorigenesis of the variant (A)8 tract produced by this allele, we undertook a somatic mutation analysis of the region surrounding codon 1307 in colorectal tumors from APC I1307K carriers. Somatic mutations involving the variant (A)8 tract were identified in 53 of 127 (42%) tumors from APC I1307K carriers compared with 5 of 127 (4%) mutations involving the wild-type allele of these tumors (P < 0.0001). Loss of heterozygosity of the wild-type allele was significantly more common in tumors with APC I1307K allele mutations (25 of 41, 61%) compared with APC I1307K carrier tumors without mutation of the variant (A)8 tract (12 of 53, 23%; P < 0.0005). This somatic biallelic APC inactivation further confirms the biological importance of the I1307K germ-line variant. The vast majority of APC I1307K somatic mutations consisted of a single adenine insertion (insA) involving the variant (A)8 tract. This insA mutation was mutually exclusive of the presence of microsatellite instability with 0 of 49 tumors with insA displaying BAT-26 instability compared with 9 of 78 tumors without insA (P=0.01). These findings support a model where somatic instability of the (A)8 tract produced by the APC I1307K allele leads to increased APC gene inactivation and directly accounts for 42% of the colorectal neoplasms occurring in APC I1307K carriers.
腺瘤性结肠息肉病基因(APC)被认为是结直肠癌发生的守门基因。该基因的一种种系变异,即APC I1307K等位基因,在约6%的阿什肯纳兹犹太人群体中存在。为了评估该等位基因产生的变异(A)8序列在肿瘤发生中的作用,我们对APC I1307K携带者的结直肠癌肿瘤中密码子1307周围区域进行了体细胞突变分析。在APC I1307K携带者的127个肿瘤中有53个(42%)检测到涉及变异(A)8序列的体细胞突变,而这些肿瘤中涉及野生型等位基因的突变有5个(4%)(P<0.0001)。与未发生变异(A)8序列突变的APC I1307K携带者肿瘤(53个中有12个,23%)相比,具有APC I1307K等位基因突变的肿瘤中野生型等位基因杂合性缺失更为常见(41个中有25个,61%;P<0.0005)。这种体细胞双等位基因APC失活进一步证实了I1307K种系变异的生物学重要性。绝大多数APC I1307K体细胞突变由单个腺嘌呤插入(insA)组成,涉及变异(A)8序列。这种insA突变与微卫星不稳定性相互排斥,49个有insA的肿瘤中有0个显示BAT-26不稳定性,并与78个没有insA的肿瘤中有9个显示不稳定性(P=0.01)相比。这些发现支持了一种模型,即由APC I1307K等位基因产生的(A)8序列的体细胞不稳定性导致APC基因失活增加,并直接导致APC I1307K携带者中42%的结直肠癌发生。